Summary
Lipid droplets (LDs) are dynamic organelles that collect, store, and supply lipids [1] . LDs have a central role in the exchange of lipids occurring between the cell and the environment and provide cells with substrates for energy metabolism, membrane synthesis, and production of lipidderived molecules such as lipoproteins or hormones. However, lipid-derived metabolites also cause progressive lipotoxicity [2] , accumulation of reactive oxygen species (ROS), endoplasmic reticulum stress, mitochondrial malfunctioning, and cell death [2] . Intracellular accumulation of LDs is a hallmark of prevalent human diseases, including obesity, steatosis, diabetes, myopathies, and arteriosclerosis [3] . Indeed, nonalcoholic fatty liver disease is the most common cause of abnormal hepatic function among adults [4, 5] . Lipotoxicity gradually promotes cellular ballooning and disarray, megamitochondria, accumulation of Mallory's hyaline in hepatocytes, and inflammation, fibrosis, and cirrhosis in the liver. Here, using confocal microscopy, serial-block-face scanning electron microscopy, and flow cytometry, we show that LD accumulation is heterogeneous within a cell population and follows a positive skewed distribution. Lipid availability and fluctuations in biochemical networks controlling lipolysis, fatty acid oxidation, and protein synthesis contribute to cell-tocell heterogeneity. Critically, this reversible variability generates a subpopulation of cells that effectively collect and store lipids. This high-lipid subpopulation accumulates more LDs and more ROS and reduces the risk of lipotoxicity to the population without impairing overall lipid homeostasis, since high-lipid cells can supply stored lipids to the other cells.
In conclusion, we demonstrate fat storage compartmentalization within a cell population and propose that this is a protective social organization to reduce lipotoxicity.
Results and Discussion

LD Accumulation Is Cell-to-Cell Heterogeneous
The liver is essential for the body's fat metabolism by storing and processing lipids and is thus persistently threatened by lipotoxicity. Although they are poorly understood, there are likely to be cellular mechanisms to simultaneously deal with the beneficial and harmful aspects of intracellular lipids. Here, to investigate whether such mechanisms exist in hepatic cells, we first examined lipid droplet (LD) distribution in mice liver sections. In control livers, there were relatively few LDs ( Figure 1A ). However, some hepatocytes clearly accumulated LDs (black globular structures, red arrows), whereas others completely lacked LDs (green arrows). Under starvation or after a partial hepatectomy, LDs accumulated (white globular structures, Figures 1B-1D ). In both cases, cell-to-cell differences in LD size and number were evident, and the highest variability occurred 48 hr after hepatectomy. To further characterize the heterogeneous LD accumulation of untreated livers, we used a new technique, serial-blockface scanning electron microscopy (3View). LDs were clearly distinguished by their electron density ( Figure 1E ). The analysis of 1,000 consecutive sections (approximately 50 mm depth) revealed the presence of LDs in all hepatocytes and demonstrated high variability between them (Movie S1 available online). As an example of cell-to-cell heterogeneity, we selected two neighboring hepatocytes for a detailed segmentation analysis ( Figure 1E , Movie S2, and Movie S3). The comparison of the volumetric occupancy of LDs demonstrated striking differences; 10.9% (97.7 mm 3 ) of the cytoplasmic volume of cell 1 was occupied by LDs, whereas only 2.6% (27.6 mm 3 ) of the volume of cell 2 was occupied by LDs ( Figures  1F and 1G ).
For analysis of whether cell-to-cell heterogeneity reflects the zonal distribution of hepatocytes within the liver, primary hepatocytes were isolated, labeled with Nile Red, and analyzed by microscopy. Only some of these hepatocytes accumulated LDs (left panel, Figure 1H ). When these hepatocytes were identically treated for 24 hr with fatty acids (FAs; albumin-bound oleate), all accumulated LDs but a high heterogeneity in LD number and size was observed (right panel, Figure 1H ). Therefore, although liver architecture is a likely source of some variability, heterogeneity seems to be essentially regulated by intracellular factors.
Extent of Heterogeneity in LD Content
LD accumulation has traditionally been studied in adipocytes, where cell-to-cell differences have been reported during progression of adipogenesis [6] . Variability has also been occasionally mentioned when LDs were promoted under laboratory conditions in clonal yeast, fibroblasts, and tumor cell lines [7] [8] [9] . Histological scoring of steatotic livers has also *Correspondence: apols@ub.edu (legend continued on next page) revealed hepatocyte-to-hepatocyte heterogeneity in human biopsies [10] . However, such variability has been masked by commonly used experimental techniques, and the degree, sources, and potential utility of cell-to-cell heterogeneity have received little attention.
To quantify LD accumulation cell by cell, we used flow cytometry. Starting from previous protocols [8] , we optimized the approach to measure the LD content of individual cells. Due to cellular aggregation, this method was not reliable for primary hepatocytes, so instead we analyzed AML12 cells (alpha mouse liver 12) [11] . Microscopy analysis demonstrated that AML12 also exhibited high heterogeneity before and after the loading with FAs ( Figure 1I ). For quantification of these differences, AML12 cells were loaded with FAs and labeled with Nile Red, and neutral lipid accumulation by individual cells was determined via flow cytometry in 1 3 10 4 cells per experiment. As expected, FA treatment increased the average LD content (red line, Figure 1J ), and it was reduced with Triacsin C (blue line, Figure 1J ), a potent inhibitor of LD formation ( Figure S1A and the Supplemental Results and Discussion). The relative increment measured by flow cytometry was identical to the result obtained with an enzymatic method ( Figure S1A and the Supplemental Results and Discussion).
The histograms and dot plots demonstrated a high heterogeneity in the cellular LD content ( Figures 1J and 1K) , with approximately 100-fold maximal cell-to-cell differences in LD levels. To measure heterogeneity, we calculated the percent robust coefficient of variation (%rCV), defined as %rCV = [(rSD / median) 3 100]. Intuitively, the %rCV measures the average deviation of an individual cell from the population median. In FA-loaded cells, the overall %rCV was 57% 6 9% ( Figure 1L ), although the most loaded 15% of the hepatocytes (arbitrary cutoff, see Figure 4 below) showed an average %rCV with respect the whole population median of 205% 6 30%. In contrast, the standard deviation between %rCV of independent experiments was only 9%, suggesting that overall the %rCV is relatively constant. When compared with other cell lines, heterogeneity was particularly high in hepatic cells (Figure S1B) . Thus, the extent of heterogeneity is different between different cell types, suggesting that it is potentially controllable.
Causes of Heterogeneity in LD Content
Next, we analyzed how environmental and intracellular factors determine heterogeneity ( Figure 2A ). To assess how lipid availability contributes to heterogeneity, we incubated AML12 cells for 24 hr with increasing FA doses. As expected, overall LD accumulation was proportional to lipid availability ( Figures  2B and 2C ). The %rCV was maximal at low concentrations and progressively decreased with higher doses ( Figure 2D ). Linear histograms reveal that with moderate concentrations of FAs (up to 250 mg/ml), the LD content of the population followed a positive skewed distribution, suggesting possible collective mechanisms to increase the mass of the distribution in low-lipid cells, by preferential accumulation of lipids in a reduced number of high-lipid cells ( Figure 2B ). In contrast, higher doses of FAs progressively decreased asymmetry (as measured by skewness, Figure 2E ), the relative percentage of cells in the low lipid range, and thus the final %rCV.
We also analyzed whether LD unloading contributes to heterogeneity. Thus, FA-loaded cells were subsequently incubated in a FA-free media for 16 hr. As expected, the LD levels were reduced, but interestingly the %rCV increased significantly (white bars, Figures 2F and 2I ). Importantly, LD unloading and heterogeneity were highly reduced by relatively low concentrations of FAs in the media. Thus, systems with prolonged circulating lipids-e.g., obese individuals-will not only increase LD formation but also reduce LD unloading and heterogeneity.
We next used specific inhibitors of intracellular processes related to LD accumulation to determine the pathways that contribute to heterogeneity ( Figure 2A To evaluate heterogeneity sources during unloading, we incubated previously FA-loaded cells for 16 hr in FA-free media but in the presence of the inhibitors. The unloading of LDs was now highly reduced when lipolysis (DEUP) and autophagy (3MA) were inhibited, suggesting that LD unloading is conducted by both mechanisms (Figures 2H and 2K) . Inhibition of mitochondrial FA uptake (ETO) and protein synthesis (CHX) also reduced LD unloading. The inhibition of lipases or mitochondrial FA uptake decreased heterogeneity. In contrast, inhibition of protein synthesis or autophagy had no effect on the %rCV, suggesting that these mechanisms are activated proportionally to the LD content of each cell. Thus, LD storage and heterogeneity are overall regulated by lipid availability, although they are also determined by the oxidation of FAs, lipolysis, and the synthesis of new protein.
Heterogeneity in LD Content Is Regulated by Reversible Mechanisms
Phenotypic heterogeneity within a cell population is well known yet poorly understood. When identical cells-or the same cell over time-respond differently to an identical stimulus, it is often caused by stochasticity in gene expression, which can reflect fluctuations of transcription and/or translation of genes and proteins [12] . In principle, stochasticity provides a mechanism for different cells in an identical population to sample different physiological states without need for irreversible genetic mutations, making it likely that at least some of the population survives/functions when faced with different types of unexpected challenges. (legend continued on next page)
Thus, we analyzed whether the heterogeneity is reversible, as expected from stochastic biochemical networks. After FA loading, the high-and low-lipid-loaded cells of the population were separated by flow cytometry using side scatter (SSC-A) as the sorting criteria. This SSC-A reflects the cell's inner complexity and is proportional to LD levels ( Figure 3A and the Supplemental Results and Discussion) [13] . With this method, the separated high-lipid cells had double the lipid content of the low-lipid cells (Figures 3B and 3C) . Next, both subpopulations were independently recultured during 7 days in standard media to metabolize LDs, eliminating the majority of LDs ( Figure 3D , ''7 days''). Finally, cells were again FA loaded, and the LD content was quantified. At an overall population level, the original high-and low-lipid cells were indistinguishable and accumulated equivalent LDs ( Figure 3D , ''7 days + 24h FA''). Importantly, the %rCV was identical for each group of newly cultured cells that had originated from different subpopulations and was identical to the %rCV of the whole population before sorting ( Figure 3E ). Thus, as expected from a process regulated by stochasticity, the cell's capacity to accumulate LDs heterogeneously is variable and reversible over time. It is likely, then, that this reversibility allows exchange of the risk of lipotoxicity between different cells of the population over time.
High-Lipid Cells Are an Advantage for the Population
The existence of cells specialized in fat storage is conserved from flies to humans, suggesting that fat compartmentalization has been a positive trait during evolution. In worms, in the absence of an authentic adipose tissue, C. elegans compartmentalizes the fat in the intestine [14] . Further, we have confirmed (data not shown) the existence of a high heterogeneity in clonal populations of unicellular organisms such as the yeast Saccharomyces cerevisiae [7] . In humans, when such compartmentalization is impaired, a series of complex metabolic effects (commonly known as lipodystrophies) is elicited in the rest of cells [15] . Lipodystrophies are associated with early multi-organ complications especially in cardiovascular and hepatic tissues that lead to diabetes and metabolic syndromes [3] . Therefore, similar to adipose tissue, we hypothesized that the existence of high-lipid cells within a cell population might potentially reduce lipotoxicity to the average cell without impairing overall lipid homeostasis.
To explore the cell-to-cell distribution of toxic metabolites, we first separated the cells into high-and low-lipid subpopulations by flow cytometry and measured reactive oxygen species (ROS) levels in each subpopulation. ROS levels were higher in high-lipid cells ( Figure 3F ). Importantly, cell-to-cell correlation studies on the whole population demonstrated that ROS levels were proportional to LD levels ( Figure 3G) . Single-cell analysis demonstrated that the 15% of cells with the highest LD levels (arbitrary cutoff) accumulate much more than 15% of the overall lipids and also have 53% more ROS than the mean of the population (distribution in Figure 3G , left, and averages of ROS for each group of cells shown in Figure 3G , right). Thus, this small percentage of high-lipid cells allows 40% of the population to have low lipids and a significant reduction of ROS (nearly 30%), which was similar to the ROS levels of these cells before the addition of FAs (data not shown). These results suggest that LD compartmentalization reduces toxic metabolites in most cells and thus is an advantage for the population.
To directly test this idea of ROS protection due to high-lipid cells, we created a set of initially low-lipid cells to act as ''indicator'' cells. These cells, cultured in standard conditions, were labeled with the fluorescent CellTrace DDAO-SE (far-red emission). The ''indicator'' cells were mixed with either (1) additional unlabeled low-lipid cells or (2) unlabeled high-lipid cells generated by treatment with 500 mg/ml FAs for 24 hr (see Figures 2B-2E) . Then, the mixed cell population was cocultured for 16 hr in either normal media or in the presence of lipotoxic palmitic acid. Finally, ROS levels were measured only in ''indicator'' cells ( Figure 4A ) or in the whole population ( Figure 4B) . Importantly, the ''indicator'' cells had less ROS when cocultured with high-lipid cells (white bar in palmitic, Figure 4A ) than with low-lipid cells (black bar in Figure 4A ), showing that indeed the presence of the high-lipid cells can decrease ROS in the low lipid cells. Surprisingly, the presence of highlipid cells was also protective during palmitic incubation for the population as a whole, since total ROS levels were significantly reduced when high-lipid cells were present in the culture (white bar in palmitic, Figure 4B ). The beneficial effects of high-lipid cells were also seen when cells were in standard media (white bars in control, Figure 4B ). Thus, high-lipid cells protect not only low-lipid cells but, importantly, reduce ROS levels to the entire population. On the basis of these findings, we suggest that high-lipid cells activate systems to reduce ROS accumulation, but these mechanisms will need to be tested in future work.
The protective effect of the high-lipid cells could be indirect (e.g., due to cell-cell communication between the two groups). However, it could be also produced by local titration of FAs from the media. This last possibility is likely, since the rate of lipid uptake was directly proportional to the cellular levels of LDs ( Figure S3 ) and when cocultured, high-lipid cells take up more lipids than ''indicator'' cells ( Figure 4C ). To test this possibility, we cocultured ''indicator'' cells with low-or high-lipid cells for 16 hr in the presence of FAs and measured the resulting LD accumulation. The ''indicator'' cells accumulated fewer LDs in the presence of high-lipid cells (Figure 4D ), supporting the hypothesis that high-lipid cells reduce accumulation of LDs to low-lipid cells and may in this way decrease overall lipotoxicity.
High-Lipid Cells Supply Lipids to the Population
The main function of an adipose tissue is first to collect and store lipids when they are in excess and then, without impairing overall lipid homeostasis, to provide these lipids to other cells when lipid availability is compromised. Therefore, to test the hypothesis that high-lipid cells are functioning-at a cellular level-as an adipose tissue, we analyzed whether Figure 4E ). However, 16 hr after coplating, the transfer of the green FA was detected. The new curves (orange for ''indicator'' cells and green for high-lipid cells) were between the original curves. Thus, ''indicator'' cells accumulated fluorescent lipids and high-lipid cells with decreased lipids had become a donor population. The exchange was confirmed by fluorescence microscopy ( Figure 4F ). Although the cellular mechanisms involved in lipid exchange will require further analysis, the unloading of the fluorescent lipid by high-lipid cells was higher in the presence of low-lipid ''indicator'' cells (white bar, Figure 4G ) than in the presence of other unlabelled high-lipid cells (black bar, Figure 4G ), suggesting possible mechanisms of cell-to-cell communication between the two groups and potentially the result of increased lipids in the media due to release of FAs from all of the high lipid cells.
Concluding Remarks
Here, we show that cellular LD storage is overall regulated by lipid availability but is also affected by cell-to-cell variable biochemical networks. Indeed, when cells of a clonal population are identically treated with extracellular lipids, the accumulation of LDs follows a heterogeneous and skewed distribution, with most cells having relatively low-lipid accumulation and a few with high-lipid storage. As expected from mechanisms regulated by reversible stochastic mechanisms, high-lipid cells are an advantage for the population: when facing toxic lipids or prolonged exposure to FAs, most cells-and, intriguingly, the whole population-have fewer toxic metabolites than would be expected for cells with that average lipid accumulation. In addition, the high-lipid cells can supply stored lipids to the low-lipid cells, effectively functioning-at a cellular level-as adipose tissue.
Intriguingly, maximal heterogeneity and skewness occur at relatively low overall levels of lipid availability, consistent with the hypothesis that mechanisms of heterogeneity are overwhelmed when exposed to excess lipids. When compared with other cell lines, heterogeneity is particularly high in hepatic cells, suggesting that this protective mechanism could be particularly important for the liver. This appears to have direct implications for NAFLD, an increasingly important chronic liver disease, because it is strongly correlated with obesity and thus with a persistent lipid exposure [16] . Such a prolonged lipid exposure will not only increase LD formation but will also reduce LD unloading and heterogeneity. In addition, other intracellular heterogeneous factors, such as the mitochondrial activity, also determine the LD content of individual hepatocytes, pinpointing additional risk factors for NAFLD development. Whether mechanisms of heterogeneity in the liver are identical to the mechanisms detailed here for hepatic cells or whether they are also determined by changes in cell physiology due to zonal arrangement will require additional analysis. Importantly, genes and proteins contributing to heterogeneity are likely to be rate-limiting steps within each network and are thus a new set of targets to modulate for potential clinical utility and also to better understand the cellular basis and risk factors for developing NAFLD.
Experimental Procedures
Reagents Nile Red, BODIPY-FLC16, Hoechst-33258, CellTrace Far Red DDAO-SE, and BODIPY 493/503 were from Molecular Probes, Invitrogen. Fatty-acidfree BSA, collagenase type IV, 2 0 ,7 0 -dichlorofluorescein diacetate (H 2 DCFDA), palmitic acid, thymidine, DEUP, 3MA, platensimycin (PTM), diethyl-p-nitrophenyl phosphate (E600), ETO, and CHX were purchased from Sigma-Aldrich. Triacsin C (TRC) was from Santa Cruz Biotechnology.
Oleic acid and mowiol were from Calbiochem. A detailed explanation of the methods used in this manuscript can be found in the Supplemental Experimental Procedures.
Statistical Analysis
All data shown in graphs are the mean and SEM, and the statistical significance were determined with the Student's t test (*p < 0.05, **p < 0.01, ***p < 0.001).
Supplemental Information
Supplemental Information includes Supplemental Results and Discussion, Supplemental Experimental Procedures, four figures, and three movies and can be found with this article online at http://dx.doi.org/10.1016/ j.cub.2013.06.032. 
